Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo

Fig. 5

The cost-effectiveness of active screening strategies. a Cost-effectiveness plane showing the total cost of a strategy and the associated total number of DALYs. Mean values for each strategy are shown by the coloured crosses. b Cost-effectiveness acceptability curves (CEACs) for each strategy are shown by lines, with the cost-effectiveness acceptability frontier (CEAF) shown by the numbered background colour, which demonstrated the values for the ICER. WTP is shown in 2018 USD on the top and as the WTPc coefficient on the bottom, where the coefficient is the multiplier of the GDP per capita of the DRC. See Table 3 for the full descriptions of the strategies

Back to article page